ALDH1A1 and breast carcinoma: Specifically, CD44 and ALDH1, two important breast CSC markers, increased 2- to 17-fold in all cell lines examined (Figure 1d), suggesting that TLR3 activation, but not TLR5, 7, and 8, associates with CSC properties in different subtypes of breast cancer cells.